Related Experiment Video

Updated: May 19, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

[Daptomycin in the treatment of infectious endocarditis]

V P Tiurin, I E Serdiuk, I P Kushenko

    Klinicheskaia Meditsina
    |August 18, 2012
    PubMed

    Insights

    New antibiotic daptomycin shows promise in treating infectious endocarditis (IE) caused by multidrug-resistant bacteria. This study highlights successful daptomycin use in four patients with challenging IE cases.

    Area of Science:

    • Infectious Diseases
    • Cardiology
    • Pharmacology

    Background:

    • Infectious endocarditis (IE) poses significant challenges due to increasing antimicrobial resistance.
    • Traditional treatments often fail against pathogens exhibiting polyresistance.
    • Novel therapeutic strategies are crucial for managing complex IE cases.

    Observation:

    • This study describes clinical features of IE caused by Enterococcus faecalis strains resistant to penicillin, gentamicin, and streptomycin.
    • Cases with negative blood cultures and prior treatment failures were analyzed.
    • Literature data on daptomycin for oxacillin-resistant Staphylococcus aureus IE is reviewed.

    Findings:

    • Daptomycin was successfully employed in four patients with infectious endocarditis.
    • The antibiotic demonstrated efficacy in treating IE caused by multidrug-resistant Enterococcus faecalis.
    • Successful outcomes were observed in challenging IE scenarios.

    Implications:

    • Daptomycin represents a valuable therapeutic option for multidrug-resistant IE.
    • Further research into daptomycin's role in specific IE populations (e.g., pregnant women, dialysis patients) is warranted.
    • The findings support the use of newer antibiotics to combat resistant IE pathogens.

    More Related Videos

    Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians06:49

    Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

    Published on: March 14, 2014

    Related Concept Videos

    Endocarditis III: Medical Management01:18

    Endocarditis III: Medical Management

    Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
    Endocarditis IV: Nursing Management01:29

    Endocarditis IV: Nursing Management

    Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
    Endocarditis I: Introduction01:25

    Endocarditis I: Introduction

    Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
    Endocarditis II: Clinical Features of Infective Endocarditis01:25

    Endocarditis II: Clinical Features of Infective Endocarditis

    Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
    Diphtheria01:28

    Diphtheria

    Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...